Crossmark

Response to the Letter to the Editor: Are SGLT-2 inhibitors “the elephant in the room” of non-diabetic glomerulonephritis? Considerations about the background immunosuppressive treatment

Crossref DOI link: https://doi.org/10.1007/s11255-023-03619-9

Published Online: 2023-04-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hammad, Hany

Shaban, Asmaa

Victor, Maryan

Fayed, Ahmed

Abdelaziz, Tarek Samy https://orcid.org/0000-0002-1238-1045
License Information

Text and Data Mining valid from 2023-04-29

Version of Record valid from 2023-04-29
More Information

Article History

Received: 23 April 2023

Accepted: 24 April 2023

First Online: 29 April 2023

Declarations

:

: All authors declare no competing interests.

Document is current

Any future updates will be listed below